Exact Mass: 408.156424
Exact Mass Matches: 408.156424
Found 500 metabolites which its exact mass value is equals to given mass value 408.156424,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Amlodipine
Amlodipine is a long-acting calcium channel blocker used as an anti-hypertensive and in the treatment of angina. As other calcium channel blockers, amlodipine acts by relaxing the smooth muscle in the arterial wall, decreasing peripheral resistance and hence improving blood pressure; in angina it improves blood flow to the myocardium. It was developed under the direction of Dr. Simon Campbell; A long acting dihydropyridine calcium channel blocker. It is effective in the treatment of angina pectoris and hypertension; in angina it improves blood flow to the myocardium.; Amlodipine (as besylate, mesylate or maleate) is a long-acting calcium channel blocker used as an anti hypertensive and in the treatment of angina. Amlodipine is marketed as Norvasc in North America and as Istin in the United Kingdom as well as under various other names. As other calcium channel blockers, amlodipine acts by relaxing the smooth muscle in the arterial wall, decreasing peripheral resistance and hence improving blood pressure; Amlodipine (as besylate, mesylate or maleate) is a long-acting calcium channel blocker used as an anti-hypertensive and in the treatment of angina. Amlodipine is marketed as Norvasc in North America and as Istin in the United Kingdom as well as under various other names. As other calcium channel blockers, amlodipine acts by relaxing the smooth muscle in the arterial wall, decreasing peripheral resistance and hence improving blood pressure; in angina it improves blood flow to the myocardium. It was developed under the direction of Dr. Simon Campbell. [HMDB] Amlodipine is a long-acting calcium channel blocker used as an anti-hypertensive and in the treatment of angina. As other calcium channel blockers, amlodipine acts by relaxing the smooth muscle in the arterial wall, decreasing peripheral resistance and hence improving blood pressure; in angina it improves blood flow to the myocardium. It was developed under the direction of Dr. Simon Campbell; A long acting dihydropyridine calcium channel blocker. It is effective in the treatment of angina pectoris and hypertension; in angina it improves blood flow to the myocardium. Amlodipine (as besylate, mesylate or maleate) is a long-acting calcium channel blocker used as an anti hypertensive and in the treatment of angina. Amlodipine is marketed as Norvasc in North America and as Istin in the United Kingdom as well as under various other names. As other calcium channel blockers, amlodipine acts by relaxing the smooth muscle in the arterial wall, decreasing peripheral resistance and hence improving blood pressure; Amlodipine (as besylate, mesylate or maleate) is a long-acting calcium channel blocker used as an anti-hypertensive and in the treatment of angina. Amlodipine is marketed as Norvasc in North America and as Istin in the United Kingdom as well as under various other names. As other calcium channel blockers, amlodipine acts by relaxing the smooth muscle in the arterial wall, decreasing peripheral resistance and hence improving blood pressure; in angina it improves blood flow to the myocardium. It was developed under the direction of Dr. Simon Campbell. C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Beclometasone
C22H29ClO5 (408.17034140000004)
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07E - Intestinal antiinflammatory agents > A07EA - Corticosteroids acting locally R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BA - Glucocorticoids D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AD - Corticosteroids D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D000893 - Anti-Inflammatory Agents
MK-329
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist Same as: D02693 Devazepide (L-364,718) is a potent, competitive, selective and orally active nonpeptide antagonist of cholecystokinin (CCK) receptor, with IC50s of 81 pM, 45 pM and 245 nM for rat pancreatic, bovine gallbladder and guinea pig brain CCK receptors, respectively. Devazepide (L-364,718) is effective for gastrointestinal disorders[1].
Nelociguat
A member of the class of pyrazolopyridines that is 1H-pyrazolo[3,4-b]pyridine which is substituted by a 2-fluorobenzyl and 4,6-diamino-5-[(methoxycarbonyl)amino]pyrimidin-2-yl groups at positions 1 and 3, respectively. It is an active metabolite of riociguat and a soluble guanylate cyclase stimulator developed by Bayer for the treatment of erectile dysfunction and heart failure. C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent
9-Hydroxycalabaxanthone
9-Hydroxycalabaxanthone is found in fruits. 9-Hydroxycalabaxanthone is a constituent of Garcinia mangostana (mangosteen)
Garcimangosone B
Garcimangosone B is found in fruits. Garcimangosone B is a constituent of the dry fruit hulls of Garcinia mangostana (mangosteen). Constituent of the dry fruit hulls of Garcinia mangostana (mangosteen). Garcimangosone B is found in fruits.
Bakkenolide D
C21H28O6S (408.16065080000004)
Constituent of Petasites japonicus (sweet coltsfoot). Bakkenolide D is found in giant butterbur and green vegetables. Bakkenolide D is found in giant butterbur. Bakkenolide D is a constituent of Petasites japonicus (sweet coltsfoot)
Mammea A/AC cyclo F
Mammea A/AC cyclo F is found in fruits. Mammea A/AC cyclo F is a constituent of Mammea americana (mamey). Constituent of Mammea americana (mamey). Mammea A/AC cyclo F is found in fruits.
8,9-Dihydro-5-hydroxy-8-(1-hydroxy-1-methylethyl)-6-(2-methyl-1-oxopropyl)-4-phenyl-2H-furo[2,3-h]-1-benzopyran-2-one
8,9-Dihydro-5-hydroxy-8-(1-hydroxy-1-methylethyl)-6-(2-methyl-1-oxopropyl)-4-phenyl-2H-furo[2,3-h]-1-benzopyran-2-one is found in fruits. 8,9-Dihydro-5-hydroxy-8-(1-hydroxy-1-methylethyl)-6-(2-methyl-1-oxopropyl)-4-phenyl-2H-furo[2,3-h]-1-benzopyran-2-one is isolated from Mammea americana (mamey) seeds. Isolated from Mammea americana (mamey) seeds. 8,9-Dihydro-5-hydroxy-8-(1-hydroxy-1-methylethyl)-6-(2-methyl-1-oxopropyl)-4-phenyl-2H-furo[2,3-h]-1-benzopyran-2-one is found in fruits.
Alclometasone
C22H29ClO5 (408.17034140000004)
Alclometasone is only found in individuals that have used or taken this drug. It is synthetic glucocorticoid steroid for topical use in dermatology as anti-inflammatory, antipruritic, antiallergic, antiproliferative and vasoconstrictive agent. [Wikipedia]The mechanism of the anti-inflammatory activity of the topical steroids, in general, is unclear. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. Alclometasone initially binds the corticosteroid receptor. This complex migrates to the nucleus where it binds to different glucocorticoid response elements on the DNA. This in turn enhances and represses various genes, especially those involved in inflammatory pathways. D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AB - Corticosteroids, moderately potent (group ii) S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BA - Corticosteroids, plain C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
6,8-Dihydroxy-1,7-diprenylxanthone-2-carboxylic acid
6,8-Dihydroxy-1,7-diprenylxanthone-2-carboxylic acid is found in fruits. 6,8-Dihydroxy-1,7-diprenylxanthone-2-carboxylic acid is a constituent of the fruit hulls of Garcinia mangostana (mangosteen). Constituent of the fruit hulls of Garcinia mangostana (mangosteen). 6,8-Dihydroxy-1,7-diprenylxanthone-2-carboxylic acid is found in fruits.
Melatonin glucuronide
C19H24N2O8 (408.15325839999997)
Melatonin glucuronide is a metabolite of melatonin. Melatonin Listen/ˌmɛləˈtoʊnɪn/, also known chemically as N-acetyl-5-methoxytryptamine, is a naturally occurring compound found in animals, plants, and microbes. In animals, circulating levels of the hormone melatonin vary in a daily cycle, thereby allowing the entrainment of the circadian rhythms of several biological functions. (Wikipedia)
beclomethasone
C22H29ClO5 (408.17034140000004)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D000893 - Anti-Inflammatory Agents
2-(2-Aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylic acid O3-ethyl ester O5-methyl ester;benzenesulfonic acid
Clobetasone
C22H26ClFO4 (408.15035580000006)
Montirelin
Sabiporide
C18H19F3N6O2 (408.15215099999995)
N-[4-(Benzylamino)-3-cyanoquinolin-2-yl]-4-methoxybenzamide
1,2-Dihydro-5-hydroxy-2-(1-hydroxy-1-methylethyl)-4-(butyryl)-6-phenylfurano[2,3-h][1]benzopyran-8-one
OCHROCARPIN E
A furanocoumarin that is 2,3-dihydro-7H-furo[2,3-f]chromen-7-one substituted by a hydroxy group at position 4, a 2-hydroxypropan-2-yl group at position 2, a 2-methylpropanoyl group at position 5 and a phenyl group at position 9. Isolated from the bark of Ochrocarpos punctatus, it exhibits cytotoxicity against the A2780 ovarian cancer cell line.
1,2-Dihydro-5-hydroxy-2- (1-hydroxy-1-methylethyl) -4- (butyryl) -6-phenylfurano [ 2,3-h ] [ 1 ] benzopyran-8-one
1,2-Dihydro-5-hydroxy-2-(1-hydroxy-1-methylethyl)-4-(isobutyryl)-6-phenylfurano[2,3-h][1]benzopyran-8-one
SSR161421
CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4517; ORIGINAL_PRECURSOR_SCAN_NO 4515 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4526; ORIGINAL_PRECURSOR_SCAN_NO 4524 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4486; ORIGINAL_PRECURSOR_SCAN_NO 4482 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4512; ORIGINAL_PRECURSOR_SCAN_NO 4511 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4511; ORIGINAL_PRECURSOR_SCAN_NO 4509 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4499; ORIGINAL_PRECURSOR_SCAN_NO 4496 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8790; ORIGINAL_PRECURSOR_SCAN_NO 8789 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8826; ORIGINAL_PRECURSOR_SCAN_NO 8825 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8842; ORIGINAL_PRECURSOR_SCAN_NO 8841 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8870; ORIGINAL_PRECURSOR_SCAN_NO 8865 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8884; ORIGINAL_PRECURSOR_SCAN_NO 8882 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8898; ORIGINAL_PRECURSOR_SCAN_NO 8897 ORIGINAL_PRECURSOR_SCAN_NO 8897; CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8898
(6aS)-6a-methyl-9-(2-methylbutyryl)-3-[(1S*,6S*)-6-methyl-2-oxocyclohex-3-enyl]-6aH-furo[2,3-h]isochromene-6,8-dione|multiformin B
2,2-Dimethyl-5,9-dihydroxy-8-(3-methyl-2-butenyl)-10-methoxy-2H,6H-pyrano[3,2-b]xanthene-6-one
1,4-Dimethyl-3-[4-(3-methyl-2-butenyloxy)benzyl]-3,6-bis(methylthio)piperazine-2,5-dione
C20H28N2O3S2 (408.15412580000003)
O-(3-Methyl-2-butenyl)-3-[(4-Hydroxyphenyl)methyl]-1,4-dimethyl-3,6-bis(methylthio)-2,5-piperazinedione
C20H28N2O3S2 (408.15412580000003)
2,2-Dimethyl-5,9-dihydroxy-8-methoxy-12-(3-methyl-2-butenyl)-2H,6H-pyrano[3,2-b]xanthene-6-one
1,5-dihydroxy-3-methoxy-4-(1,1-dimethylprop-2-enyl)-18,18-dimethyl-2H-pyrano[7,6-b]xanthen-9-one|pedunxanthone C
2,3-Dimethoxy-7,8-didehydro-7,16-seco-strychnidin-10,16-dion|2,3-dimethoxy-7,8-didehydro-7,16-seco-strychnidine-10,16-dione
1-[2,4-Dihydroxy-3-(2-hydroxybenzyl)-6-methoxyphenyl]-3-(4-methoxyphenyl)-1-propanone
1-O-(3-methylbut-3-en-1-yl)-6-O-beta-D-xylopyranosyl-beta-D-glucopyranose|nonioside L
C17H28O11 (408.16315380000003)
5-oxobrucine
A monoterpenoid indole alkaloid with formula C23H24N2O5, originallly isolated from the seeds of Strychnos nux-vomica.
Garciniaxanthone F
An organic heteropentacyclic compound that is 6H-furo[3,2-c]xanthen-6-one substituted by hydroxy groups at positions 7 and 10, 2-methoxypropan-2-yl group at position 2 and a 2-methylbut-3-en-2-yl group at position 8. Isolated from the woods of Garcinia subelliptica, it exhibits antioxidant activity.
Bakkenolide D
C21H28O6S (408.16065080000004)
amlodipine
C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 1544
MLS001333651-01!Dehydroisoandrosterone 3-sulfate sodium salt hydrate1099-87-2
C19H29NaO6S (408.15824540000006)
Ala Cys Cys Ile
Ala Cys Cys Leu
Ala Cys Ile Cys
Ala Cys Leu Cys
Ala Asp Phe Gly
Ala Asp Gly Phe
Ala Phe Asp Gly
Ala Phe Gly Asp
Ala Gly Asp Phe
Ala Gly Phe Asp
Ala Gly Met Met
Ala Ile Cys Cys
Ala Leu Cys Cys
Ala Met Gly Met
Ala Met Met Gly
Ala Met Ser Thr
Ala Met Thr Ser
Ala Ser Met Thr
Ala Ser Thr Met
Ala Thr Met Ser
Ala Thr Ser Met
Cys Ala Cys Ile
Cys Ala Cys Leu
Cys Ala Ile Cys
Cys Ala Leu Cys
Cys Cys Ala Ile
Cys Cys Ala Leu
Cys Cys Ile Ala
Cys Cys Leu Ala
Cys Gly Met Val
Cys Gly Val Met
Cys Ile Ala Cys
Cys Ile Cys Ala
Cys Ile Ser Ser
Cys Leu Ala Cys
Cys Leu Cys Ala
Cys Leu Ser Ser
Cys Met Gly Val
Cys Met Val Gly
Cys Ser Ile Ser
Cys Ser Leu Ser
Cys Ser Ser Ile
Cys Ser Ser Leu
Cys Ser Thr Val
Cys Ser Val Thr
Cys Thr Ser Val
Cys Thr Val Ser
Cys Val Gly Met
Cys Val Met Gly
Cys Val Ser Thr
Cys Val Thr Ser
Asp Ala Phe Gly
Asp Ala Gly Phe
Asp Phe Ala Gly
Asp Phe Gly Ala
Asp Gly Ala Phe
Asp Gly Phe Ala
Asp Ser Ser Thr
C14H24N4O10 (408.14923639999995)
Asp Ser Thr Ser
C14H24N4O10 (408.14923639999995)
Asp Thr Ser Ser
C14H24N4O10 (408.14923639999995)
Glu Phe Gly Gly
Glu Gly Phe Gly
Glu Gly Gly Phe
Glu Ser Ser Ser
C14H24N4O10 (408.14923639999995)
Phe Ala Asp Gly
Phe Ala Gly Asp
Phe Asp Ala Gly
Phe Asp Gly Ala
Phe Glu Gly Gly
Phe Gly Ala Asp
Phe Gly Asp Ala
Phe Gly Glu Gly
Phe Gly Gly Glu
Gly Ala Asp Phe
Gly Ala Phe Asp
Gly Ala Met Met
Gly Cys Met Val
Gly Cys Val Met
Gly Asp Ala Phe
Gly Asp Phe Ala
Gly Glu Phe Gly
Gly Glu Gly Phe
Gly Phe Ala Asp
Gly Phe Asp Ala
Gly Phe Glu Gly
Gly Phe Gly Glu
Gly Gly Glu Phe
Gly Gly Phe Glu
Gly Met Ala Met
Gly Met Cys Val
Gly Met Met Ala
Gly Met Thr Thr
Gly Met Val Cys
Gly Thr Met Thr
Gly Thr Thr Met
Gly Val Cys Met
Gly Val Met Cys
Ile Ala Cys Cys
Ile Cys Ala Cys
Ile Cys Cys Ala
Ile Cys Ser Ser
Ile Ser Cys Ser
Ile Ser Ser Cys
Leu Ala Cys Cys
Leu Cys Ala Cys
Leu Cys Cys Ala
Leu Cys Ser Ser
Leu Ser Cys Ser
Leu Ser Ser Cys
Met Ala Gly Met
Met Ala Met Gly
Met Ala Ser Thr
Met Ala Thr Ser
Met Cys Gly Val
Met Cys Val Gly
Met Gly Ala Met
Met Gly Cys Val
Met Gly Met Ala
Met Gly Thr Thr
Met Gly Val Cys
Met Met Ala Gly
Met Met Gly Ala
Met Ser Ala Thr
Met Ser Thr Ala
Met Thr Ala Ser
Met Thr Gly Thr
Met Thr Ser Ala
Met Thr Thr Gly
Met Val Cys Gly
Met Val Gly Cys
Ser Ala Met Thr
Ser Ala Thr Met
Ser Cys Ile Ser
Ser Cys Leu Ser
Ser Cys Ser Ile
Ser Cys Ser Leu
Ser Cys Thr Val
Ser Cys Val Thr
Ser Asp Ser Thr
C14H24N4O10 (408.14923639999995)
Ser Asp Thr Ser
C14H24N4O10 (408.14923639999995)
Ser Glu Ser Ser
C14H24N4O10 (408.14923639999995)
Ser Ile Cys Ser
Ser Ile Ser Cys
Ser Leu Cys Ser
Ser Leu Ser Cys
Ser Met Ala Thr
Ser Met Thr Ala
Ser Ser Cys Ile
Ser Ser Cys Leu
Ser Ser Asp Thr
C14H24N4O10 (408.14923639999995)
Ser Ser Glu Ser
C14H24N4O10 (408.14923639999995)
Ser Ser Ile Cys
Ser Ser Leu Cys
Ser Ser Ser Glu
C14H24N4O10 (408.14923639999995)
Ser Ser Thr Asp
C14H24N4O10 (408.14923639999995)
Ser Thr Ala Met
Ser Thr Cys Val
Ser Thr Asp Ser
C14H24N4O10 (408.14923639999995)
Ser Thr Met Ala
Ser Thr Ser Asp
C14H24N4O10 (408.14923639999995)
Ser Thr Val Cys
Ser Val Cys Thr
Ser Val Thr Cys
Thr Ala Met Ser
Thr Ala Ser Met
Thr Cys Ser Val
Thr Cys Val Ser
Thr Asp Ser Ser
C14H24N4O10 (408.14923639999995)
Thr Gly Met Thr
Thr Gly Thr Met
Thr Met Ala Ser
Thr Met Gly Thr
Thr Met Ser Ala
Thr Met Thr Gly
Thr Ser Ala Met
Thr Ser Cys Val
Thr Ser Asp Ser
C14H24N4O10 (408.14923639999995)
Thr Ser Met Ala
Thr Ser Ser Asp
C14H24N4O10 (408.14923639999995)
Thr Ser Val Cys
Thr Thr Gly Met
Thr Thr Met Gly
Thr Val Cys Ser
Thr Val Ser Cys
Val Cys Gly Met
Val Cys Met Gly
Val Cys Ser Thr
Val Cys Thr Ser
Val Gly Cys Met
Val Gly Met Cys
Val Met Cys Gly
Val Met Gly Cys
Val Ser Cys Thr
Val Ser Thr Cys
Val Thr Cys Ser
Val Thr Ser Cys
1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-7-(sulfooxy)-, endo-
9-Hydroxycalabaxanthone
Garcimangosone B
6,8-Dihydroxy-1,7-diprenylxanthone-2-carboxylic acid
Clobetasone
C22H26ClFO4 (408.15035580000006)
D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AB - Corticosteroids, moderately potent (group ii) S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BA - Corticosteroids, plain C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
6,8-Difluoro-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid ethyl ester
C19H22F2N4O4 (408.16090360000004)
Levamlodipine
C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C93038 - Cation Channel Blocker
(2R,3R)-1-CARBOXY-4-IODO-2,3-DIHYDROXYCYCLOHEXA-4,6-DIENE,95
Montirelin
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C76367 - Thyrotropin-Releasing Hormone Analogue D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
2-[(3S)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-2-oxoazepan-1-yl]acetic acid
(1R,2S)-Ethyl 1-amino-2-vinylcyclopropanecarboxylate hemisulfate
2-amino-6-[5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoylamino]hexanoic acid,hydrochloride
C16H29ClN4O4S (408.15979440000007)
3-[(dimethylvinylsilyl)oxy]-1,1,5,5-tetramethyl-3-phenyl-1,5-divinyltrisiloxane
11,12-Dihydro-11,12-diphenylindolo[2,3-a]carbazole
Triethylene glycol 4-methylbenzyl ether tosylate
C21H28O6S (408.16065080000004)
N-(TRIPHENYLPHOSPHORANYLIDENE)-1H-BENZOTRIAZOLE-1-METHANAMINE
N-[4-(Benzylamino)-3-cyanoquinolin-2-yl]-4-methoxybenzamide
Sabiporide
C18H19F3N6O2 (408.15215099999995)
C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent
2-(5-butoxy-1-oxo-2-isoquinolinyl)-N-(2,3-dihydro-1,4-benzodioxin-6-yl)acetamide
N-[3-[2-(1-cyclohexenyl)ethylamino]-2-quinoxalinyl]benzenesulfonamide
[1-(1-Methyl-4,5-dioxo-pent-2-enylcarbamoyl)-2-phenyl-ethyl]-carbamic acid benzyl ester
Alclometasone
C22H29ClO5 (408.17034140000004)
D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AB - Corticosteroids, moderately potent (group ii) S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BA - Corticosteroids, plain C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
Devazepide
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist Devazepide (L-364,718) is a potent, competitive, selective and orally active nonpeptide antagonist of cholecystokinin (CCK) receptor, with IC50s of 81 pM, 45 pM and 245 nM for rat pancreatic, bovine gallbladder and guinea pig brain CCK receptors, respectively. Devazepide (L-364,718) is effective for gastrointestinal disorders[1].
(9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
C22H29ClO5 (408.17034140000004)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D000893 - Anti-Inflammatory Agents
N-[4-(dibutylsulfamoyl)phenyl]-2-thiophen-2-ylacetamide
C20H28N2O3S2 (408.15412580000003)
3-[5-[Bis(3-methyl-5-oxo-1,2-dihydropyrazol-4-yl)methyl]-2-furanyl]benzoic acid methyl ester
2-[[3-(2,6-dimethyl-4-morpholinyl)-2-quinoxalinyl]thio]-N-phenylacetamide
N-[4-[[2-[1-(4-methoxyphenyl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl]thio]phenyl]acetamide
2-(4-Fluorophenyl)-4-quinolinecarboxylic acid [2-oxo-2-(2-oxolanylmethylamino)ethyl] ester
2-Cyano-3-{4-[(2,4-dimethyl-phenylcarbamoyl)-methoxy]-3-methoxy-phenyl}-acrylic acid ethyl ester
2-(3,4-dimethoxyphenyl)-N-[(E)-[1-(4-nitrophenyl)pyrrol-2-yl]methylideneamino]acetamide
(2R,3R,4S)-1-(benzenesulfonyl)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2S,3R,4R)-1-(benzenesulfonyl)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2S,3S,4S)-1-(benzenesulfonyl)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2S,3S,4R)-1-(benzenesulfonyl)-3-[4-(cyclohexen-1-yl)phenyl]-4-(hydroxymethyl)azetidine-2-carbonitrile
(2R,3S,4S)-1-(benzenesulfonyl)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
1-[(2S,3S)-6-[1,3-benzodioxol-5-yl(oxo)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]-1-propanone
(2S,3R,4S)-1-(benzenesulfonyl)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2R,3R,4R)-1-(benzenesulfonyl)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
1-[(2R,3R)-6-[1,3-benzodioxol-5-yl(oxo)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]-1-propanone
1-[(2S,3R)-6-[1,3-benzodioxol-5-yl(oxo)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]-1-propanone
3-Ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-3,4-dihydropyridine-3,5-dicarboxylate
(Z)-2-cyano-N-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-3-naphthalen-2-ylprop-2-enamide
(2S)-2-[(2-aminoacetyl)amino]-N-[2-[2-[[(2S)-2-[(2-aminoacetyl)amino]propanoyl]amino]ethyldisulfanyl]ethyl]propanamide
Dehydroisoandrosterone 3-sulfate sodium salt hydrate
C19H29NaO6S (408.15824540000006)
8,9-Dihydro-5-hydroxy-8-(1-hydroxy-1-methylethyl)-6-(2-methyl-1-oxopropyl)-4-phenyl-2H-furo[2,3-h]-1-benzopyran-2-one
LY2444296
LY2444296 is an orally bioavailable, high-affinity and selective short-acting kappa opioid receptor (KOPR) antagonist, with a Ki value of ～1 nM. LY2444296 exhibits anti-anxiety like effects[1][2].
RBC10
RBC10 is an anti-cancer agent. RBC10 inhibits the binding of Ral to its effector RALBP1. RBC10 also inhibits Ral-mediated cell spreading of murine embryonic fibroblasts and anchorage-independent growth of human cancer cell lines[1].
Tyrosylleucine (TFA)
Tyrosylleucine (Tyr-Leu, YL) TFA, an orally active dipeptide, exhibits a potent antidepressant-like activity[1].
methyl (2r)-4-hydroxy-2-{[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]methyl}-5-oxo-3-phenylfuran-2-carboxylate
methyl 4-hydroxy-2-{[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]methyl}-5-oxo-3-phenylfuran-2-carboxylate
methyl 6,7-dimethoxy-16-methyl-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1,3,5,7,9,11,18-heptaene-19-carboxylate
5,9-dihydroxy-10-methoxy-2,2-dimethyl-12-(2-methylbut-3-en-2-yl)-1,11-dioxatetracen-6-one
methyl (1r,9r,10r,12r)-4-methoxy-15,20-dioxo-8,16-diazahexacyclo[8.8.2.2⁹,¹².0¹,⁹.0²,⁷.0¹²,¹⁶]docosa-2,4,6,13-tetraene-8-carboxylate
3',6'-dimethyl-1h,1''h-dispiro[2-benzoxepine-3,2'-[1,4]dioxane-5',3''-[2]benzoxepine]-9,9''-diol
3-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-4-yl 3-(methylsulfanyl)prop-2-enoate
C21H28O6S (408.16065080000004)
5,9-dihydroxy-8-methoxy-2,2-dimethyl-10-(3-methylbut-2-en-1-yl)-1,11-dioxatetracen-6-one
1,5-dihydroxy-3-methoxy-6',6'-dimethyl-2h-pyrano(2',3':6,7)-4-(3-methylbut-2-enyl)xanthone
{"Ingredient_id": "HBIN001659","Ingredient_name": "1,5-dihydroxy-3-methoxy-6',6'-dimethyl-2h-pyrano(2',3':6,7)-4-(3-methylbut-2-enyl)xanthone","Alias": "NA","Ingredient_formula": "C24H24O6","Ingredient_Smile": "CC(=CCC1=C(C=C(C2=C1OC3=C(C4=C(C=CC(O4)(C)C)C=C3C2=O)O)O)OC)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5973","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
anhydromangostanol*
{"Ingredient_id": "HBIN016170","Ingredient_name": "anhydromangostanol*","Alias": "NA","Ingredient_formula": "C24H24O6","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1277","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
bakkenolide d
C21H28O6S (408.16065080000004)
{"Ingredient_id": "HBIN017535","Ingredient_name": "bakkenolide d","Alias": "NA","Ingredient_formula": "C21H28O6S","Ingredient_Smile": "CC1CCC(C2C1(CC3(C2OC(=O)C)C(=C)COC3=O)C)OC(=O)C=CSC","Ingredient_weight": "408.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2120","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "137705098","DrugBank_id": "NA"}
4-[2-(13-bromo-6,10-dimethyltrideca-3,5-dien-12-yn-2-yl)cyclopropyl]butanoic acid
(8s)-5-hydroxy-8-(2-hydroxypropan-2-yl)-6-(2-methylpropanoyl)-4-phenyl-8h,9h-furo[2,3-h]chromen-2-one
(3r,6r)-1,4-dimethyl-3-[(4-{[(1e)-3-methylbut-1-en-1-yl]oxy}phenyl)methyl]-3,6-bis(methylsulfanyl)piperazine-2,5-dione
C20H28N2O3S2 (408.15412580000003)
(2r,3ar,7ar)-3-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-4-yl 3-(methylsulfanyl)prop-2-enoate
C21H28O6S (408.16065080000004)
(2r)-4-hydroxy-2-(2-hydroxypropan-2-yl)-5-(2-methylpropanoyl)-9-phenyl-2h,3h-furo[2,3-f]chromen-7-one
5,8-dihydroxy-9-methoxy-2,2-dimethyl-10-(3-methylbut-2-en-1-yl)-1,11-dioxatetracen-6-one
6-butanoyl-5,7-dihydroxy-8-[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]-4-phenylchromen-2-one
5-hydroxy-4-methoxy-16,16-dimethyl-13-(3-methylbut-2-en-1-yl)-2,9,15-trioxatetracyclo[9.8.0.0³,⁸.0¹⁴,¹⁹]nonadeca-1(11),3(8),4,6,12,14(19),17-heptaen-10-one
methyl 6,7,15-trihydroxy-17-methoxy-11-methyl-13-oxo-3,12-dioxatricyclo[12.4.0.0²,⁴]octadeca-1(18),8,14,16-tetraene-7-carboxylate
1-(1-hydroxy-8-methoxy-3-methyl-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-2-yl)ethanone
5,7-dihydroxy-6-[(2s)-2-hydroxy-3-methylbut-3-en-1-yl]-8-(2-methylpropanoyl)-4-phenylchromen-2-one
(2s)-2-{[(2s)-2-{[(2r)-2-[(2-amino-1-hydroxyethylidene)amino]-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxypropylidene]amino}butanedioic acid
2-({3',5'-dimethoxy-[1,1'-biphenyl]-4'-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
(8s)-6-butanoyl-5-hydroxy-8-(2-hydroxypropan-2-yl)-4-phenyl-8h,9h-furo[2,3-h]chromen-2-one
8-butanoyl-5,7-dihydroxy-6-(2-hydroxy-3-methylbut-3-en-1-yl)-4-phenylchromen-2-one
7-methoxy-5-methyl-2-(2-oxopropyl)-8-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one
5,9-dihydroxy-10-methoxy-2,2-dimethyl-8-(3-methylbut-2-en-1-yl)-1,11-dioxatetracen-6-one
(2r,3r,3ar,4s,7s,7ar)-4-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl (2z)-3-(methylsulfanyl)prop-2-enoate
C21H28O6S (408.16065080000004)
(2r,3r,3ar,4s,7s,7ar)-3-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-4-yl (2z)-3-(methylsulfanyl)prop-2-enoate
C21H28O6S (408.16065080000004)
(1r)-1-[(2s,4s,6s)-10-(acetyloxy)-11,12-dimethoxy-8-oxo-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),10,12-trien-4-yl]propyl acetate
4,8-dihydroxy-7-methoxy-6-(3-methylbut-2-en-1-yl)-2-(prop-1-en-2-yl)-2h,3h-furo[3,2-b]xanthen-5-one
(2s)-4,8-dihydroxy-7-methoxy-6-(3-methylbut-2-en-1-yl)-2-(prop-1-en-2-yl)-2h,3h-furo[3,2-b]xanthen-5-one
5,10-dihydroxy-9-methoxy-2,2-dimethyl-12-(2-methylbut-3-en-2-yl)-1,11-dioxatetracen-6-one
{3,4,5-trihydroxy-6-[(4-methyl-5-oxooxolan-3-yl)oxy]oxan-2-yl}methyl 3-phenylprop-2-enoate
7-methoxy-5-methyl-2-(2-oxopropyl)-8-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one
5,9-dihydroxy-10-methoxy-2,2-dimethyl-12-(3-methylbut-2-en-1-yl)-1,11-dioxatetracen-6-one
2-{16-methyl-20-oxo-15-oxa-1,11-diazapentacyclo[15.3.1.0⁴,¹².0⁵,¹⁰.0¹³,¹⁸]henicosa-4(12),5,7,9,13-pentaen-11-yl}-2-oxoethyl acetate
(2r,3r,3ar,4s,7s,7ar)-3-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-4-yl (2e)-3-(methylsulfanyl)prop-2-enoate
C21H28O6S (408.16065080000004)
(2s)-2-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl)-2h,3h-furo[3,2-g]chromen-7-one
methyl (2r,4r,6s,8e,11s)-6,7,15-trihydroxy-17-methoxy-11-methyl-13-oxo-3,12-dioxatricyclo[12.4.0.0²,⁴]octadeca-1(18),8,14,16-tetraene-7-carboxylate
8-butanoyl-5,7-dihydroxy-6-[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]-4-phenylchromen-2-one
(2s,3s,4s,5s,6r)-2-{2-[2-(3,4-dihydroxyphenyl)ethyl]-4-hydroxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
8-[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one
2-[(16r,17s,18r)-16-methyl-20-oxo-15-oxa-1,11-diazapentacyclo[15.3.1.0⁴,¹².0⁵,¹⁰.0¹³,¹⁸]henicosa-4(12),5,7,9,13-pentaen-11-yl]-2-oxoethyl acetate
3,4',6-trimethoxy-4-(4-methoxyphenyl)-[1,1'-biphenyl]-2-yl acetate
methyl (2r,4r,8z,11s)-6,7,15-trihydroxy-17-methoxy-11-methyl-13-oxo-3,12-dioxatricyclo[12.4.0.0²,⁴]octadeca-1(18),8,14,16-tetraene-7-carboxylate
(3r,6s)-1,4-dimethyl-3-({4-[(3-methylbut-2-en-1-yl)oxy]phenyl}methyl)-3,6-bis(methylsulfanyl)piperazine-2,5-dione
C20H28N2O3S2 (408.15412580000003)
(1r,6r,13r)-13-hydroxy-16,17-dimethoxy-6-(prop-1-en-2-yl)-2,7-dioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3(11),4(8),9,14,16,18-hexaen-12-one
1,4-dimethyl-3-({4-[(3-methylbut-1-en-1-yl)oxy]phenyl}methyl)-3,6-bis(methylsulfanyl)piperazine-2,5-dione
C20H28N2O3S2 (408.15412580000003)
8,8-dimethyl-9-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-9h,10h-pyrano[2,3-h]chromen-2-one
(2r,3s)-3-[(1r,2s,3s,7s,8r,10r)-10-hydroxy-2,13-dimethyl-4,11-dioxo-5,9-dioxatetracyclo[6.5.1.0²,¹⁰.0³,⁷]tetradec-12-en-7-yl]-2-methylpentanedioic acid
4-[(1r,2r)-2-[(2s,3e,5e,10r)-13-bromo-6,10-dimethyltrideca-3,5-dien-12-yn-2-yl]cyclopropyl]butanoic acid
[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-{[(2z)-3-phenylprop-2-enoyl]oxy}oxan-2-yl]methyl 4-hydroxy-2-methylidenebutanoate
13-hydroxy-16,17-dimethoxy-6-(prop-1-en-2-yl)-2,7-dioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3(11),4(8),9,14,16,18-hexaen-12-one
[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(3s,4s)-4-methyl-5-oxooxolan-3-yl]oxy}oxan-2-yl]methyl (2e)-3-phenylprop-2-enoate
(2r,3s)-3-[(1r,2r,3s,7s,8r,10r)-10-hydroxy-2,13-dimethyl-4,11-dioxo-5,9-dioxatetracyclo[6.5.1.0²,¹⁰.0³,⁷]tetradec-12-en-7-yl]-2-methylpentanedioic acid
(7s,8s)-5-chloro-7-hydroxy-8-[(3s,4s)-4-hydroxy-3-methyl-2-oxopentyl]-7-methyl-3-[(1e,3s)-3-methylpent-1-en-1-yl]-8h-isochromen-6-one
C22H29ClO5 (408.17034140000004)
(8r)-6-butanoyl-5-hydroxy-8-(2-hydroxypropan-2-yl)-4-phenyl-8h,9h-furo[2,3-h]chromen-2-one
2,4',6-trimethoxy-4-(4-methoxyphenyl)-[1,1'-biphenyl]-3-yl acetate
6-(4-hydroxy-3-methylbut-2-en-1-yl)-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one
{3,4,5-trihydroxy-6-[(3-phenylprop-2-enoyl)oxy]oxan-2-yl}methyl 4-hydroxy-2-methylidenebutanoate
6,12-dihydroxy-8-methoxy-2,2-dimethyl-7-(3-methylbut-2-en-1-yl)-1,10-dioxatetraphen-5-one
(1r,4r,7r,11s,13r,18s,19s)-4,5,7,8,17-pentahydroxy-14,18-dimethyl-6-methylidene-3,10-dioxapentacyclo[9.8.0.0¹,⁷.0⁴,¹⁹.0¹³,¹⁸]nonadec-14-ene-9,16-dione
(1s,4as,5r,7s,7as)-4a,5-dihydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydrocyclopenta[c]pyran-7-yl acetate
C17H28O11 (408.16315380000003)
(1r,3r,6s,8s,10r,11r,13s,16s,17r)-8-tert-butyl-6,17-dihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0¹,¹¹.0³,⁷.0⁷,¹¹.0¹³,¹⁷]nonadecane-5,15,18-trione
methyl (2r,4r,6s,7r,8e,11s)-6,7,15-trihydroxy-17-methoxy-11-methyl-13-oxo-3,12-dioxatricyclo[12.4.0.0²,⁴]octadeca-1(18),8,14,16-tetraene-7-carboxylate
6-butanoyl-5,7-dihydroxy-8-(2-hydroxy-3-methylbut-3-en-1-yl)-4-phenylchromen-2-one
7-hydroxy-8-(3-methyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-2-en-1-yl)chromen-2-one
4-hydroxy-6-[4-hydroxy-3-(2-methylprop-1-en-1-yl)phenyl]-2-(2-hydroxypropan-2-yl)-2h,3h-furo[3,2-g]chromen-5-one
(1s,6r,8r,12r,13s,23r)-16-methoxy-4-methyl-7,10-dioxa-4,14-diazaheptacyclo[10.8.3.2¹¹,¹⁴.0¹,¹³.0⁶,⁸.0⁶,²³.0¹⁵,²⁰]pentacosa-11(25),15(20),16,18-tetraene-21,24-dione
22-hydroxy-10-methoxy-7,7,18,18-tetramethyl-8,13,17-trioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(22),3,9,11,14,16(21),19-heptaen-2-one
8-(4-hydroxy-3-methylbut-2-en-1-yl)-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one
4-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-(methylsulfanyl)prop-2-enoate
C21H28O6S (408.16065080000004)
5,9-dihydroxy-8-methoxy-2,2-dimethyl-12-(3-methylbut-2-en-1-yl)-1,11-dioxatetracen-6-one
(2r,3s)-3-[(1r,3s,7s,8r,10r)-10-hydroxy-2,13-dimethyl-4,11-dioxo-5,9-dioxatetracyclo[6.5.1.0²,¹⁰.0³,⁷]tetradec-12-en-7-yl]-2-methylpentanedioic acid
5,7-dihydroxy-8-(2-hydroxy-3-methylbut-3-en-1-yl)-6-(2-methylpropanoyl)-4-phenylchromen-2-one
18-acetyl 18-methyl (1s,10s,12r,13e)-13-ethylidene-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵]octadeca-2,4,6,8-tetraene-18,18-dicarboxylate
(3r,6r)-1,4-dimethyl-3-({4-[(3-methylbut-2-en-1-yl)oxy]phenyl}methyl)-3,6-bis(methylsulfanyl)piperazine-2,5-dione
C20H28N2O3S2 (408.15412580000003)
(2s)-4-hydroxy-2-(2-hydroxypropan-2-yl)-5-(2-methylpropanoyl)-9-phenyl-2h,3h-furo[2,3-f]chromen-7-one
8-[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]-7-{[(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one
(9r)-8,8-dimethyl-9-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-9h,10h-pyrano[2,3-h]chromen-2-one
methyl (2r,4r,6s,7r,8z,11s)-6,7,15-trihydroxy-17-methoxy-11-methyl-13-oxo-3,12-dioxatricyclo[12.4.0.0²,⁴]octadeca-1(18),8,14,16-tetraene-7-carboxylate
7-hydroxy-8-[(2e)-3-methyl-4-{[(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-2-en-1-yl]chromen-2-one
2-(2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl)-2h,3h-furo[3,2-g]chromen-7-one
(1r,3r,6r,7s,8s,10s,11s,13s,16s,17r)-8-tert-butyl-6,17-dihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0¹,¹¹.0³,⁷.0⁷,¹¹.0¹³,¹⁷]nonadecane-5,15,18-trione
(6as)-6a-methyl-3-[(1s,6s)-6-methyl-2-oxocyclohex-3-en-1-yl]-9-(2-methylbutanoyl)furo[2,3-h]isochromene-6,8-dione
(6as)-6a-methyl-3-[(1r,6r)-6-methyl-2-oxocyclohex-3-en-1-yl]-9-[(2r)-2-methylbutanoyl]furo[2,3-h]isochromene-6,8-dione
(3s,6r)-1,4-dimethyl-3-({4-[(3-methylbut-2-en-1-yl)oxy]phenyl}methyl)-3,6-bis(methylsulfanyl)piperazine-2,5-dione
C20H28N2O3S2 (408.15412580000003)
(2r)-2-(2-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl)-2h,3h-furo[3,2-g]chromen-7-one
7,12-dihydroxy-9-methoxy-2,2-dimethyl-10-(3-methylbut-2-en-1-yl)-1,11-dioxatetracen-6-one
(1r,3r,6s,7s,8s,10r,11s,13s,16s,17r)-8-tert-butyl-6,17-dihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0¹,¹¹.0³,⁷.0⁷,¹¹.0¹³,¹⁷]nonadecane-5,15,18-trione
7-hydroxy-8-[(2e)-3-methyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-2-en-1-yl]chromen-2-one
1,4-dimethyl-3-({4-[(3-methylbut-2-en-1-yl)oxy]phenyl}methyl)-3,6-bis(methylsulfanyl)piperazine-2,5-dione
C20H28N2O3S2 (408.15412580000003)
6a-methyl-3-(6-methyl-2-oxocyclohex-3-en-1-yl)-9-(2-methylbutanoyl)furo[2,3-h]isochromene-6,8-dione
(2s)-4-hydroxy-6-[4-hydroxy-3-(2-methylprop-1-en-1-yl)phenyl]-2-(2-hydroxypropan-2-yl)-2h,3h-furo[3,2-g]chromen-5-one
(1s,3r,6r,7s,8s,10r,11s,13s,16r,17s)-8-tert-butyl-6,17-dihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0¹,¹¹.0³,⁷.0⁷,¹¹.0¹³,¹⁷]nonadecane-5,15,18-trione
(2s,3s,3as,4r,7r,7as)-3-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-4-yl (2e)-3-(methylsulfanyl)prop-2-enoate
C21H28O6S (408.16065080000004)
1-(2-{[4-(but-1-en-1-yl)-2,5-dioxofuran-3-yl]methyl}butylidene)butane-1,2,4-tricarboxylic acid
1-(4-{[1,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)propan-2-yl]oxy}-3,5-dimethoxyphenyl)-2-hydroxyethanone
(3s,6s)-1,4-dimethyl-3-({4-[(3-methylbut-2-en-1-yl)oxy]phenyl}methyl)-3,6-bis(methylsulfanyl)piperazine-2,5-dione
C20H28N2O3S2 (408.15412580000003)